Resources

In low- and middle-income countries, many women experience anemia during pregnancy due to insufficient dietary intake of key micronutrients, parasitic infections, hemoglobinopathies, and chronic infections. Maternal anemia increases perinatal risks for both mothers and infants, and slow progress to reduce the prevalence may be due in part to the lack of affordable tools to quantify hemoglobin levels in antenatal care (ANC) clinics. A simple, inexpensive, accurate, and robust diagnostic is needed to measure hemoglobin in ANC.PATH sought to understand and assess the accuracy and operational fit of current anemia diagnostic tools. Our approach began with the development of a target product profile and a landscape of commercially available/emerging diagnostics for anemia testing.We then identified promising candidate technologies and conducted laboratory verification testing and usability testing in a representative ANC setting.This project resulted in a body of evidence that can be used to evaluate and select promising anemia diagnostic technologies to take to scale now and in the future.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings from Democratic Republic of the Congo in 2019-2020.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings from Uganda from 2019-2020.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings from Senegal from 2019-2020.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2019 with a focus on evaluating progress and analyzing impact of grants funded through the 2017-2019 allocation and implemented during 2018-2019. Findings were structured around three out of the four Global Fund strategic objectives (SOs): grant implementation and contribution to disease impact (SO1); grant contribution to national Resilient and Sustainable Systems for Health outcomes (SO2); and grant contribution to national program key population, human rights, and gender-related outcomes (SO3).